Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 174.35 USD 1.53%
Market Cap: 308.1B USD
Have any thoughts about
Abbvie Inc?
Write Note

P/E
Price to Earnings

59.7
Current
30.3
Median
22.2
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
59.7
=
Market Cap
303.5B USD
/
Net Income
5.1B USD
All Countries
Close
Market Cap P/E
US
Abbvie Inc
NYSE:ABBV
303.5B USD 59.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -180 080
US
Amgen Inc
NASDAQ:AMGN
155.8B USD 36.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.1B USD -241.9
US
Gilead Sciences Inc
NASDAQ:GILD
111.8B USD 887.6
US
Epizyme Inc
F:EPE
94.1B EUR -474.5
AU
CSL Ltd
ASX:CSL
132.3B AUD 32.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82B USD 17.6
US
Seagen Inc
F:SGT
39.3B EUR -54.9
NL
argenx SE
XBRU:ARGX
33.8B EUR -127.7
KY
Beigene Ltd
SSE:688235
233.5B CNY -53.4
Earnings Growth
US
Abbvie Inc
NYSE:ABBV
Average P/E: 206.9
59.7
412%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Amgen Inc
NASDAQ:AMGN
36.8
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
887.6
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.7 N/A
KY
Beigene Ltd
SSE:688235
Negative Multiple: -53.4 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
15.4
2-Years Forward
P/E
13.9
3-Years Forward
P/E
12.3

See Also

Discover More